Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy

• Main Authors: Yusuf Turkoz (Author), Hamdi Er (Author), Mehmet Borazan (Author), Harun Yılmaz (Author), Bülent Mızrak (Author), Hakan Parlakpınar (Author), Yılmaz Çigremis (Author)
• Formato: Livro
• Publicado em: Hindawi Limited, 2004-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

PURPOSE: To investigate whether caffeic acid phenethyl ester (CAPE) and cortisone prevent proliferative vitreoretinopathy (PVR).